Companies producing affordable generic medicines for poor people could be subject to criminal prosecutions and have their medicines seized on orders from big drug companies under plans being drawn up by a closed group of mainly rich countries
17 Feb – Pharmaceutical giant GlaxoSmithKline should be congratulated for breaking industry ranks and taking a major step toward helping poor people in developing countries to get better access to medicines, says international agency Oxfam. However GSK’s initiative this week is just the beginning.
Aggressive patenting costs lives, says Oxfam. Legal maneuvering by multinational companies restricting access to essential medicines contradicts their encouraging words at the International AIDS Conference.
Aware of Starbucks’ status as a global brand interested in maintaining its socially responsible reputation, Oxfam used grassroots activism and strategic media to draw attention to the issue. Now, Ethiopian farmers coaxed a groundbreaking agreement out of Starbucks.